A term infant with neonatal opioid withdrawal syndrome is cared for in a hospital using the Eat, Sleep, Console approach and is at risk for pharmacologic treatment. The team is considering whether symptom-based opioid dosing or a scheduled opioid taper is better supported by recent randomized evidence.
What does the evidence in this abstract support for infants with NOWS cared for with the Eat, Sleep, Console approach?
